SH3-domain binding protein 1 in the tumor microenvironment promotes hepatocellular carcinoma metastasis through WAVE2 pathway.

Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51

A perspective on cancer cell metastasis. Science (2011) 13.31

Matrix metalloproteinases: regulators of the tumor microenvironment. Cell (2010) 12.90

Microenvironmental regulation of tumor progression and metastasis. Nat Med (2013) 8.37

Targeting hypoxia in cancer therapy. Nat Rev Cancer (2011) 7.10

Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell (2006) 4.33

Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg (2011) 3.10

Classifying collective cancer cell invasion. Nat Cell Biol (2012) 2.83

ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma. Cancer Cell (2011) 2.77

Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology (2011) 2.66

Nucleating actin for invasion. Nat Rev Cancer (2011) 2.22

HCC and angiogenesis: possible targets and future directions. Nat Rev Clin Oncol (2011) 2.10

SH3BP1, an exocyst-associated RhoGAP, inactivates Rac1 at the front to drive cell motility. Mol Cell (2011) 1.70

RAC1 activation mediates Twist1-induced cancer cell migration. Nat Cell Biol (2012) 1.69

Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. Oncotarget (2012) 1.55

Rac-WAVE2 signaling is involved in the invasive and metastatic phenotypes of murine melanoma cells. Oncogene (2005) 1.45

FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma. Clin Cancer Res (2005) 1.29

Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region- containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma. Hepatology (2010) 1.16

Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma. Clin Cancer Res (2011) 1.15

Membrane and actin dynamics interplay at lamellipodia leading edge. Curr Opin Cell Biol (2013) 1.07

Rac activation is associated with hepatocellular carcinoma metastasis by up-regulation of vascular endothelial growth factor expression. Clin Cancer Res (2006) 0.99

Revisiting G3BP1 as a RasGAP binding protein: sensitization of tumor cells to chemotherapy by the RasGAP 317-326 sequence does not involve G3BP1. PLoS One (2011) 0.97

Rac1 modulates TGF-beta1-mediated epithelial cell plasticity and MMP9 production in transformed keratinocytes. FEBS Lett (2010) 0.94

Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma. Clin Cancer Res (2006) 0.89

Control of Rho GTPase function by BAR-domains. Small GTPases (2012) 0.87

Formation and functions of asymmetric microtubule organization in polarized cells. Curr Opin Cell Biol (2012) 0.87

A novel Rac1 GAP splice variant relays poly-Ub accumulation signals to mediate Rac1 inactivation. Mol Biol Cell (2012) 0.82

Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression. Sci Rep (2017) 0.78

Complete response of early stage hepatocellular carcinoma in a patient treated with combination therapy of camrelizumab (SHR-1210) and apatinib. Dig Liver Dis (2019) 0.75